Opus Genetics (IRD) Cash from Investing Activities (QoQ) (2010 - 2019)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -104.12% |
| Sep 30, 2019 | 0.21% |
| Jun 30, 2019 | 150.78% |
| Mar 31, 2019 | -394.76% |
| Dec 31, 2018 | -45.42% |
| Sep 30, 2018 | 12.79% |
| Jun 30, 2018 | 8.39% |
| Mar 31, 2018 | 197.87% |
| Dec 31, 2017 | -202.21% |
| Sep 30, 2017 | 129.91% |
| Jun 30, 2017 | -1,510.17% |
| Mar 31, 2017 | -84.82% |
| Dec 31, 2016 | 345.47% |
| Sep 30, 2016 | -176.96% |
| Jun 30, 2016 | 423.23% |
| Mar 31, 2016 | 82.08% |
| Dec 31, 2015 | -161.46% |
| Sep 30, 2015 | 164.08% |
| Jun 30, 2015 | -37.79% |
| Mar 31, 2015 | 289.66% |
| Dec 31, 2014 | 89.12% |
| Sep 30, 2014 | -27,500.15% |
| Jun 30, 2014 | 159.92% |
| Mar 31, 2014 | -90.68% |
| Dec 31, 2013 | 1,983.23% |
| Sep 30, 2013 | -96.17% |
| Jun 30, 2013 | 189.00% |
| Mar 31, 2013 | 115.32% |
| Dec 31, 2012 | -259.98% |
| Sep 30, 2012 | -76.85% |
| Jun 30, 2012 | 1,412.64% |
| Mar 31, 2012 | -89.62% |
| Dec 31, 2011 | 559.11% |
| Sep 30, 2011 | -66.41% |
| Jun 30, 2011 | 122.97% |
| Mar 31, 2011 | -176.46% |
| Dec 31, 2010 | -170.28% |